Healthcare Times Utah: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Times Utah.

Press releases published on August 6, 2026

6 hours ago

Nano-X Imaging Ltd. Announces Pricing of a $8 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Indeterminate GlobeNewswire

6 hours ago

Zhengye Biotechnology Holding Limited Regains Compliance with Nasdaq Bid Price Requirement

Indeterminate GlobeNewswire

6 hours ago

Belite Bio to Host Webcast on August 13, 2026, to Discuss Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

6 hours ago

Ascendis Announces COACH Week 78 Results and Provides Update on Achondroplasia Programs and YUVIWEL® Uptake in the U.S.

Indeterminate GlobeNewswire

6 hours ago

Clearmind Reaches Key Clinical Trial Milestone as DSMB Unanimously Clears Progression in AUD Study

Indeterminate GlobeNewswire

7 hours ago

argenx Announces Commencement of Tender Offer to Acquire Forte Biosciences, Inc.

Indeterminate GlobeNewswire

7 hours ago

SAB BIO Reports Q2 2026 Financial Results and Provides Business Highlights

Indeterminate GlobeNewswire

7 hours ago

Collegium Reports Second Quarter 2026 Financial Results and Highlights Recent Company Progress

Indeterminate GlobeNewswire

7 hours ago

Abeona Therapeutics® to Host Second Quarter 2026 Financial Results Conference Call on August 13, 2026

Indeterminate GlobeNewswire

7 hours ago

Compass Therapeutics Reports 2026 Second Quarter Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

7 hours ago

BioVie Announces Topline Results of Phase 2 SUNRISE-PD Trial of Bezisterim in Early Parkinson’s Disease

Indeterminate GlobeNewswire

7 hours ago

Cronos Group Reports 2026 Second Quarter Results

Indeterminate GlobeNewswire

7 hours ago

Lexicon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Clinical Updates 

Indeterminate GlobeNewswire

7 hours ago

Cerenome Selects XiFin Empower RCM for Revenue Cycle Management and Clearinghouse Services for CNSide Platform

Indeterminate GlobeNewswire

7 hours ago

InflaRx Reports Second Quarter 2026 Results and Highlights Key Achievements and Expected Milestones

Indeterminate GlobeNewswire

7 hours ago

Alterity Therapeutics to Present at the 46th Annual Canaccord Genuity Growth Conference

Indeterminate GlobeNewswire

7 hours ago

Tarsus Reports Second Quarter 2026 Financial Results, Advances Next Phase of Growth

Indeterminate GlobeNewswire

7 hours ago

Ocugen Provides Business Update with Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

7 hours ago

Tarsus Pharmaceuticals Announces Oversubscribed $125.0 Million Private Placement Equity Financing

Indeterminate GlobeNewswire

7 hours ago

Iovance Biotherapeutics Reports Record Second Quarter 2026 Revenue of ~$99M, Business Achievements, and Corporate Updates

Indeterminate GlobeNewswire